
    
      Primary outcome:

      Better detection of comorbidity and geriatric syndromes in vulnerable patients Better
      detection of a degradation of the quality of life at D0 (at diagnosis)

      Secondary outcomes:

      Better support for quality of life and psychological support after mastectomy (revaluation to
      6 months) Integration of patients in the geriatric sector and implementation of regular
      monitoring Study design: prospective, multicenter
    
  